GAITHERSBURG, Md., Aug. 05, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc.
(Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery,
development and commercialization of recombinant nanoparticle vaccines and
adjuvants, today announced that Stanley C. Erck, President and CEO, will present
...
↧